Contrast ultrasound for the quantification of deep vein thrombosis in living mice: Effects of enoxaparin and P2Y12 receptor inhibition

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 6, 2013, Pages 1154-1162

  Guenther, F ^a   Herr, N ^a   Mauler, M ^a   Witsch, T ^a   Roming, F ^a   Hein, L ^b   Boeynaems, J M ^c   Robaye, B ^c   Idzko, M ^d   Bode, C ^a   Von Zur Muhlen, C ^a   Duerschmied, D ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Contrast enhanced ultrasound; Deep vein thrombosis; P2Y12 receptor

Indexed keywords

ENOXAPARIN; PURINERGIC P2Y12 RECEPTOR; SONOVUE; TICAGRELOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; REAL TIME ULTRASOUND SCANNER; WILD TYPE;

CONTRAST-ENHANCED ULTRASOUND; DEEP VEIN THROMBOSIS; P2Y12 RECEPTOR;

ADENOSINE; ANIMALS; ANTICOAGULANTS; CHLORIDES; CONTRAST MEDIA; ENOXAPARIN; FERRIC COMPOUNDS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROBUBBLES; MICROSCOPY; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; SIGNAL TRANSDUCTION; SULFUR HEXAFLUORIDE; THROMBOSIS; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 84883786787     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12206     Document Type: Article

References (26)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 370-2. 28/3/370 [pii].
2. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: I9-16.
3. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M, Pauker SG, Makdissi R, Guyatt GH. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2_suppl): e351S-418S. 141/2_suppl/e351S [pii].
4. Denis CV, Dubois C, Brass LF, Heemskerk JW, Lenting PJ. Towards standardization of in vivo thrombosis studies in mice. J Thromb Haemost 2011; 9: 1641-4.
5. Aghourian MN, Lemarie CA, Blostein MD. In vivo monitoring of venous thrombosis in mice. J Thromb Haemost 2012; 10: 447-52.
6. Wang X, Smith PL, Hsu MY, Ogletree ML, Schumacher WA. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor. J Thromb Haemost 2006; 4: 403-10.
7. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2_suppl): e419S-94S. 141/2_suppl/e419S [pii].
8. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 1959-67.
9. Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308: 235-46.
10. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367: 1979-87.
11. Ben Addi A, Cammarata D, Conley PB, Boeynaems JM, Robaye B. Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 2010; 185: 5900-6. jimmunol.0901799 [pii].
12. Andre P, Delaney SM, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips DR, Conley PB. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398-406. [pii].
13. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-68.
14. Diaz JA, Obi AT, Myers DD Jr, Wrobleski SK, Henke PK, Mackman N, Wakefield TW. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 556-62. 32/3/556 [pii].
15. Zhou J, May L, Liao P, Gross PL, Weitz JI. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol 2009; 29: 863-9. ATVBAHA.109.185678 [pii].
16. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-35. jem.20112322 [pii].
17. Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Kollnberger M, Wakefield TW, Lammle B, Massberg S, Wagner DD. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117: 1400-7. blood-2010-05-287623 [pii].
18. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49. 359/9/938 [pii].
19. Bird JE, Wang X, Smith PL, Barbera F, Huang C, Schumacher WA. A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis. J Thromb Thrombolysis 2012; 34: 199-207.
20. Gachet C, Hechler B. The platelet P2 receptors in thrombosis. Semin Thromb Hemost 2005; 31: 162-7.
21. Kuijpers MJ, Munnix IC, Cosemans JM, Vlijmen BV, Reutelingsperger CP, Egbrink MO, Heemskerk JW. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition. Microcirculation 2008; 15: 269-82. 790772205 [pii].
22. Stolla M, Stefanini L, Roden RC, Chavez M, Hirsch J, Greene T, Ouellette TD, Maloney SF, Diamond SL, Poncz M, Woulfe DS, Bergmeier W. The kinetics of alphaIIbbeta3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy. Blood 2011; 117: 1005-13. blood-2010-07-297713 [pii].
23. Spiss V, Loizides A, Plaikner M, Ostermann S, Peer S, Gruber H. Contrast Enhanced Ultrasound of the lower limb deep venous system: a technical feasibility study technical innovation. Med Ultrason 2011; 13: 267-71.
24. Guenther F, von zur Muhlen C, Ferrante EA, Grundmann S, Bode C, Klibanov AL. An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol 2010; 45: 586-91.
25. Wang X, Hagemeyer CE, Hohmann JD, Leitner E, Armstrong PC, Jia F, Olschewski M, Needles A, Peter K, Ahrens I. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 2012; 125: 3117-26. CIRCULATIONAHA.111.030312 [pii].
26. Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009; 6: 475-81. nrcardio.2009.77 [pii].